Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

PDR001 Plus Imatinib for Metastatic or Unresectable GIST

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03609424
Recruitment Status : Recruiting
First Posted : August 1, 2018
Last Update Posted : June 24, 2021
Information provided by (Responsible Party):
Yoon-Koo Kang, Asan Medical Center

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 30, 2022
Estimated Study Completion Date : August 30, 2022